Literature DB >> 30378499

Vascular Damage in Obesity and Diabetes: Highlighting Links Between Endothelial Dysfunction and Metabolic Disease in Zebrafish and Man.

Lucas Moritz Wiggenhauser1, Jens Kroll1.   

Abstract

Endothelial dysfunction is an initial pathophysiological mechanism of vascular damage and is further recognized as an independent predictor of negative prognosis in diabetes-induced micro- and macrovascular complications. Insight into the capability of zebrafish to model metabolic disease like obesity and type II diabetes has increased and new evidence on the induction of vascular pathologies in zebrafish through metabolic disease is available. Here, we raise the question, if zebrafish can be utilized to study the initial impairments of vascular complications in metabolic disorders. In this review, we focus on the advances made to develop models of obesity and type II diabetes in zebrafish, discuss the key points and characteristics of these models, while highlighting the available information linked to the development of endothelial dysfunction in zebrafish and man. We show that larval and adult zebrafish develop metabolic dysregulation in the settings of obesity and diabetes, exhibiting pathophysiological mechanisms, which mimic the human condition. The most important genes related to endothelial dysfunction are present in zebrafish and further display similar functions as in mammals. Several suggested contributors to endothelial dysfunction found in these models, namely hyperinsulinaemia, hyperglycaemia, hyperlipidaemia and hyperleptinaemia are highlighted and the available data from zebrafish are summarised. Many underlying processes of endothelial dysfunction in obesity and diabetes are fundamentally present in zebrafish and provide ground for the assumption, that zebrafish can develop endothelial dysfunction. Conservation of basic biological mechanisms is established for zebrafish, but focused investigation on the subject is now needed as validation and particularly more research is necessary to understand the differences between zebrafish and man. The available data demonstrate the relevance of zebrafish as a model for metabolic disease and their ability to become a proponent for the investigation of vascular damage in the settings of obesity and diabetes. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Endothelial function; danio rerio; diabetes mellitus; endothelial dysfunction; macrovascular complications; microvascular complications; obesity; zebrafish.

Mesh:

Substances:

Year:  2019        PMID: 30378499     DOI: 10.2174/1570161116666181031101413

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  9 in total

1.  The combination of loss of glyoxalase1 and obesity results in hyperglycemia.

Authors:  Elisabeth Lodd; Lucas M Wiggenhauser; Jakob Morgenstern; Thomas H Fleming; Gernot Poschet; Michael Büttner; Christoph T Tabler; David P Wohlfart; Peter P Nawroth; Jens Kroll
Journal:  JCI Insight       Date:  2019-06-20

2.  Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetes.

Authors:  Zayana M Al-Dahmani; Xiaogang Li; Lucas M Wiggenhauser; Hannes Ott; Paul D Kruithof; Sergey Lunev; Fernando A Batista; Yang Luo; Amalia M Dolga; Nicholas M Morton; Matthew R Groves; Jens Kroll; Harry van Goor
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

3.  A zebrafish pparγ gene deletion reveals a protein kinase network associated with defective lipid metabolism.

Authors:  Yan Zhao; L Filipe C Castro; Óscar Monroig; Xiaojuan Cao; Yonghua Sun; Jian Gao
Journal:  Funct Integr Genomics       Date:  2022-03-15       Impact factor: 3.674

Review 4.  Zebrafish: A New Promise to Study the Impact of Metabolic Disorders on the Brain.

Authors:  Batoul Ghaddar; Nicolas Diotel
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

5.  Diphlorethohydroxycarmalol Isolated from Ishige okamurae Exerts Vasodilatory Effects via Calcium Signaling and PI3K/Akt/eNOS Pathway.

Authors:  Yu An Lu; Yunfei Jiang; Hye-Won Yang; Jin Hwang; You-Jin Jeon; Bomi Ryu
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

6.  High Remnant Cholesterol Level Potentiates the Development of Hypertension.

Authors:  Ming-Ming Chen; Xuewei Huang; Chengsheng Xu; Xiao-Hui Song; Ye-Mao Liu; Dongai Yao; Huiming Lu; Gang Wang; Gui-Lan Zhang; Ze Chen; Tao Sun; Chengzhang Yang; Fang Lei; Juan-Juan Qin; Yan-Xiao Ji; Peng Zhang; Xiao-Jing Zhang; Lihua Zhu; Jingjing Cai; Feng Wan; Zhi-Gang She; Hongliang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-09       Impact factor: 5.555

Review 7.  Advancing Diabetic Retinopathy Research: Analysis of the Neurovascular Unit in Zebrafish.

Authors:  Chiara Simone Middel; Hans-Peter Hammes; Jens Kroll
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

8.  Diabetic vasculopathy: macro and microvascular injury.

Authors:  Roberto I Mota; Samuel E Morgan; Edward M Bahnson
Journal:  Curr Pathobiol Rep       Date:  2020-01-27

9.  Reduced Acrolein Detoxification in akr1a1a Zebrafish Mutants Causes Impaired Insulin Receptor Signaling and Microvascular Alterations.

Authors:  Haozhe Qi; Felix Schmöhl; Xiaogang Li; Xin Qian; Christoph T Tabler; Katrin Bennewitz; Carsten Sticht; Jakob Morgenstern; Thomas Fleming; Nadine Volk; Ingrid Hausser; Elena Heidenreich; Rüdiger Hell; Peter Paul Nawroth; Jens Kroll
Journal:  Adv Sci (Weinh)       Date:  2021-07-18       Impact factor: 16.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.